Shandong Weigao Group Med... (SHWGY)

AI Score

Unlock

2.96

-0.49 (-14.20%)

At close: Apr 22, 2025, 2:59 PM

Shandong Weigao Medical Polymer Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	13.23B	13.4B	13.57B	13.66B	13.75B	13.9B	14.06B	13.63B	13.21B	12.92B	12.64B	12.13B	11.62B	11.14B	10.66B	10.52B	10.38B	9.99B	9.6B	9.21B	8.81B	7.97B	7.13B	5.71B	5.4B	5.51B	5.62B	6.48B	6.24B	6.08B
Cost of Revenue	6.62B	6.53B	6.44B	6.45B	6.45B	6.53B	6.61B	6.24B	5.87B	5.73B	5.58B	5.36B	5.14B	4.71B	4.28B	4.09B	3.9B	3.72B	3.54B	3.43B	3.31B	3B	2.69B	2.02B	1.9B	1.97B	2.04B	2.55B	2.5B	2.45B
Gross Profit	6.61B	6.87B	7.13B	7.21B	7.29B	7.37B	7.45B	7.39B	7.34B	7.19B	7.05B	6.77B	6.48B	6.42B	6.37B	6.43B	6.49B	6.27B	6.06B	5.78B	5.5B	4.97B	4.44B	3.69B	3.5B	3.54B	3.58B	3.94B	3.73B	3.62B
Operating Income	2.18B	2.48B	2.78B	2.91B	3.04B	3.1B	3.15B	3.08B	3B	2.84B	2.67B	2.54B	2.4B	2.39B	2.37B	2.34B	2.31B	2.2B	2.1B	1.95B	1.8B	1.67B	1.53B	1.35B	1.33B	1.22B	1.11B	1.16B	1.07B	1.17B
Interest Income	241.95M	223.25M	204.55M	171.25M	137.95M	147M	156.06M	154.62M	153.17M	142.51M	131.85M	150.74M	169.64M	177.03M	184.43M	204.14M	223.86M	202.02M	180.18M	163.25M	146.32M	138.1M	129.88M	129.69M	98.55M	102.78M	107M	65.75M	55.45M	46.61M
Pretax Income	2.37B	2.64B	2.91B	3.15B	3.39B	3.33B	3.27B	3.07B	2.88B	2.87B	2.87B	2.72B	2.57B	2.46B	2.36B	2.3B	2.25B	2.2B	2.15B	1.96B	1.78B	1.66B	1.54B	1.46B	1.5B	1.34B	1.19B	1.2B	1.09B	1.21B
Net Income	2B	2.22B	2.44B	2.6B	2.76B	2.68B	2.59B	2.43B	2.28B	2.29B	2.3B	2.19B	2.09B	2B	1.91B	1.88B	1.85B	1.8B	1.76B	1.62B	1.47B	1.39B	1.3B	1.26B	1.3B	1.16B	1.03B	1.01B	913.86M	1.01B
Selling & General & Admin	3.84B	3.79B	3.75B	3.72B	3.69B	3.72B	3.76B	3.79B	3.83B	3.86B	3.9B	3.78B	3.65B	3.64B	3.62B	3.7B	3.78B	3.7B	3.62B	3.5B	3.38B	3.01B	2.63B	2.09B	1.92B	2.06B	2.21B	2.47B	2.37B	2.15B
Research & Development	731.38M	725.74M	720.09M	697.38M	674.66M	668.1M	661.53M	639.93M	618.33M	611.45M	604.57M	575.02M	545.47M	520.79M	496.12M	508.39M	520.67M	480.87M	441.07M	426.23M	411.39M	344.28M	277.18M	249.15M	257.76M	261.9M	266.04M	302.3M	301.91M	297.29M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	4.21B	4.18B	4.15B	4.03B	3.9B	4.05B	4.19B	4.33B	4.47B	4.33B	4.18B	4.03B	3.87B	3.85B	3.83B	3.92B	4.01B	3.9B	3.8B	3.72B	3.65B	3.21B	2.76B	2.21B	2.06B	2.25B	2.45B	2.75B	2.65B	2.42B
Interest Expense	156.27M	290.71M	290.71M	134.45M	134.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	2.58B	2.59B	2.6B	2.57B	2.54B	2.59B	2.65B	2.67B	2.7B	2.67B	2.64B	2.58B	2.53B	2.59B	2.65B	2.71B	2.78B	2.69B	2.6B	2.52B	2.44B	2.25B	2.05B	1.68B	1.59B	1.57B	1.55B	1.74B	1.64B	1.59B
Cost & Expenses	10.83B	10.71B	10.59B	10.47B	10.36B	10.58B	10.8B	10.57B	10.35B	10.06B	9.76B	9.39B	9.01B	8.56B	8.11B	8.01B	7.91B	7.62B	7.34B	7.15B	6.96B	6.21B	5.46B	4.23B	3.96B	4.23B	4.49B	5.3B	5.15B	4.88B
Income Tax Expense	307.58M	343.76M	379.93M	407.76M	435.59M	441.11M	446.62M	433.35M	420.07M	413.16M	406.25M	382.33M	358.42M	358.31M	358.19M	342.66M	327.14M	324.97M	322.8M	290.61M	258.43M	236.4M	214.36M	179.3M	167.16M	160.5M	153.84M	176.82M	176.89M	181.77M
Shares Outstanding (Basic)	287.99M	287.99M	281.74M	281.74M	284.73M	284.73M	281.31M	281.31M	283.61M	283.61M	281.17M	281.17M	287.12M	287.12M	279.77M	279.77M	284.31M	284.31M	279.77M	279.77M	279.77M	279.77M	279.77M	279.77M	282.65M	279.77M	280.26M	278.71M	282.65M	282.65M
Shares Outstanding (Diluted)	283.12M	283.12M	281.74M	281.74M	284.52M	284.52M	281.31M	281.31M	283.37M	283.37M	281.17M	281.17M	281.85M	281.85M	279.77M	279.77M	280.58M	280.58M	279.77M	279.77M	280.71M	280.71M	279.77M	279.77M	282.65M	279.77M	277.09M	277.09M	282.65M	282.65M
EPS (Basic)	6.96	7.80	8.64	9.28	9.92	9.60	9.28	8.64	8.00	8.00	8.00	7.68	7.36	7.04	6.72	6.56	6.40	6.28	6.16	5.72	5.28	4.96	4.64	4.52	4.64	4.16	3.68	3.60	3.28	3.64
EPS (Diluted)	7.04	7.84	8.64	9.28	9.92	9.60	9.28	8.64	8.00	8.00	8.00	7.68	7.36	7.04	6.72	6.56	6.40	6.28	6.16	5.72	5.28	4.96	4.64	4.52	4.64	4.16	3.68	3.60	3.28	3.64
EBITDA	3.05B	3.31B	3.57B	3.69B	3.81B	3.8B	3.79B	3.75B	3.71B	3.53B	3.35B	3.22B	3.09B	3.05B	3.01B	2.96B	2.9B	2.8B	2.7B	2.54B	2.37B	2.16B	1.96B	1.74B	1.69B	1.57B	1.46B	1.51B	1.4B	1.5B
EBIT	890.44M	1.74B	1.74B	854.55M	854.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	869.38M	828.52M	787.65M	776.82M	765.98M	702.33M	638.67M	672.12M	705.58M	691.45M	677.33M	682.8M	688.27M	666.66M	645.05M	620.49M	595.93M	598.6M	601.27M	581.91M	562.56M	496.43M	430.31M	396.57M	362.83M	357.54M	352.24M	341.88M	331.51M	323.94M